Communiqués Nuvectra Corporation

Actions

NVTRQ

US67075N1081

Temps Différé OTC Markets Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^USD	-.--%		+16,67%	-85,26%

2019	Transcript : Nuvectra Corporation, Q2 2019 Earnings Call, Jul 31, 2019
2019	Nuvectra Corporation révise ses prévisions de revenus pour 2019	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

NUVECTRA CORP : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	20/04/20	AQ
NUVECTRA CORP : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	25/03/20	AQ
NUVECTRA CORP : Other Events, Financial Statements and Exhibits (form 8-K)	16/03/20	AQ
NUVECTRA CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	13/02/20	AQ
NUVECTRA CORP : Other Events (form 8-K)	31/01/20	AQ
NUVECTRA CORP : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	15/01/20	AQ
NUVECTRA CORP : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	31/12/19	AQ
Nuvectra® Continuing to Support Current Patients with the Algovita® Implant as Company Voluntarily Files for Chapter 11	12/11/19	GL
Nuvectra Submits Chemical Composition and Biocompatibility Data to FDA for Virtis™	18/10/19	GL
Nuvectra® Appoints Jennifer Kosharek as Chief Financial Officer	20/09/19	GL
Nuvectra® Exploring Strategic Options to Enhance Shareholder Value	26/08/19	GL
Nuvectra® Reports Second Quarter 2019 Financial Results	31/07/19	GL
Nuvectra to Report Second Quarter 2019 Financial Results on July 31, 2019	17/07/19	GL
Nuvectra® to Participate in Two Upcoming Investor Conferences	12/06/19	GL
Nuvectra Files Regulatory Submission with FDA for Algovita® Full-Body MR-Conditional Approval	11/06/19	GL
Nuvectra Highlights Positive Preliminary Algovita® Clinical Data at the INS 14th Annual World Congress	30/05/19	GL
Nuvectra to Report First Quarter 2019 Financial Results on May 1, 2019	22/04/19	GL
Nuvectra® Reports Fourth Quarter and Full Year 2018 Financial Results	28/02/19	GL
Nuvectra® to Present at 39th Annual Cowen Healthcare Conference	26/02/19	GL
Nuvectra to Report Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019	19/02/19	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Nuvectra Corporation

Actions

NVTRQ

US67075N1081

Communiqués

Filtres